CureGene

CureGene Pharmaceutical Co., Ltd. possesses core platform technology and highly efficient independent innovation capabilities. The company is currently focusing on therapeutic areas such as cardiovascular and cerebrovascular diseases and antiviral treatments, striving to become an innovative drug company based in China with a global presence. CureGene has successfully developed multiple innovative pipeline drugs with broad market value and global independent intellectual property rights based on its own platform technology. It is actively promoting the clinical development of several pipelines. Driven by the company’s mission and vision, CureGene has gathered a group of high-level scientists and returned overseas talents with a global perspective. Under the guidance of the company’s comprehensive strategic layout, CureGene has successfully achieved rapid and efficient transformation of R&D results, and all of its R&D pipelines have the potential to become First-in-Class or Best-in-Class drugs.